Finance

Lists
AQST:NASDAQ
Aquestive Therapeutics Inc
4,57 $
+0,44%
(+0,020) 1D
4,56 $
-0,22% (-0,010)
Pre-market
Closed: 5 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AQST...
Open
4,57 $
High
4,61 $
Low
4,46 $
Mkt. cap
573,59 մլն
Avg. vol.
2,42 մլն
Volume
0,00
52-wk high
7,55 $
52-wk low
2,93 $
EPS
-0,65 $
Beta
1,49
Shares outstanding
125,51 մլն
No. of employees
147
Open
4,57 $
High
4,61 $
Low
4,46 $
Mkt. cap
573,59 մլն
Avg. vol.
2,42 մլն
Volume
0,00
52-wk high
7,55 $
52-wk low
2,93 $
EPS
-0,65 $
Beta
1,49
Shares outstanding
125,51 մլն
No. of employees
147
News stories
From web sources and news partners
About Aquestive Therapeutics Inc
CEO-
Employees147
Founded2004
HeadquartersWarren, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to AQST in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AQST in the last 3 months.
Highest
Current 4,57 $
10,00 $ (+118,82%)
Average
8,67 $ (+89,72%)
Lowest
6,00 $ (+31,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Maintained
10,00 $
+118,8%
09/21/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
10,00 $
+118,8%
09/17/2026
Thomas Flaten
Lake Street
Buy
Maintained
6,00 $
+31,3%
09/17/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
11,00 $
+140,7%
06/25/2026
Andreas Argyrides
Chardan Capital
Buy
Reiterated
8,00 $
+75,1%
06/25/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
9,00 $
+96,9%
05/15/2026
David Amsellem
Piper Sandler
Buy
Reiterated
8,00 $
+75,1%
05/15/2026
James Molloy
Alliance Global Partners
Buy
Maintained
9,00 $
+96,9%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,81 մլն
13,02 մլն
14,45 մլն
13,82 մլն
Cost of goods sold
4,51 մլն
5,84 մլն
3,47 մլն
4,02 մլն
Cost of revenue
4,51 մլն
5,84 մլն
3,47 մլն
4,02 մլն
Research and development expenses
4,53 մլն
3,20 մլն
4,20 մլն
3,96 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,25 մլն
32,82 մլն
10,98 մլն
14,06 մլն
Operating expense
19,78 մլն
36,02 մլն
15,18 մլն
18,02 մլն
Total operating expenses
24,29 մլն
41,85 մլն
18,65 մլն
22,04 մլն
Operating income
-11,48 մլն
-28,84 մլն
-4,20 մլն
-8,22 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-15,45 մլն
-31,86 մլն
-8,06 մլն
-22,86 մլն
EBT excluding unusual items
-15,45 մլն
-31,86 մլն
-8,06 մլն
-11,18 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,45 մլն
-31,86 մլն
-8,06 մլն
-22,86 մլն
Net profit margin
-120,61%
-244,79%
-55,77%
-165,45%
Earnings per share
-0,11
-0,14
-0,05
-0,07
Interest and investment income
306,00 հզր
1,25 մլն
83,00 հզր
882,00 հզր
Interest expense
-4,27 մլն
-4,27 մլն
-3,94 մլն
-3,84 մլն
Net interest expenses
-3,97 մլն
-3,02 մլն
-3,85 մլն
-2,96 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,34 մլն
-28,68 մլն
-4,09 մլն
-8,09 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps